In questo numero: Melanoma Bridge 2017 | Michael Postow | Michael A. Davies | Thomas F. Gajewski | Ena Wang | Jeffrey E. Gershenwald | Merrick Ross

read online | #116 - 12/2017


Michael Postow of Memorial Sloan Kettering Cancer Center on combinations and doses in immunotherapy of melanoma.

Michael A. Davies of MD Anderson Cancer Center, Texas on the clinical significance of obesity in advanced melanoma.

Thomas F. Gajewski of the University of Chicago Medicine on tumor and host genomics regulating immunotherapy efficacy.

What did we learn about melanoma in the last years and how could we use this knowledge? Let’s hear Ena Wang of Sidra Medical Centre, Doha.

Jeffrey E. Gershenwald of the Department of Surgical Oncology of The University of Texas MD Anderson Cancer Center.

We met in Naples Merrick Ross of the Department of Surgical Oncology of The University of Texas MD Anderson Cancer Center.


Si ringrazia, per il supporto non condizionato a questo numero:

Bristol-Myers Squibb

UNA PUBBLICAZIONE DE IL PENSIERO SCIENTIFICO EDITORE
ISSN 2385-0108

cancella la mia iscrizione

 

oncoinfo.it 2017 © Think2it | All rights reserved